ARCHIVES

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

NCI Funds Proteomic Technology Assessment Grants.

September 29, 2006

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

October 26, 2012

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

June 19, 1981